agonism

Some Beta-1 agonism also results in contraction of the heart muscle.

Moreover, overall agonism rates in blue monkeys are very low.

Even when agonism escalates to actual fighting, restraint may be used.

It works via agonism of the κ-opioid receptors in the brain.

However, there are also other mechanisms of adrenergic agonism.

The administration of the racemate results in the overall β agonism responsible for its activity.

Agonism is opposed to a strand in the Marxist conception of politics known as "materialism".

Agonism is based on contestation, but in a political space where the discourse is one of respect, rather than violence.

In general, levels of agonism (or aggression) tend to correlate with relative canine height.

Presence of a competitive antagonist will shift an agonism dose-response curve to the right.

A full agonism was displayed on α-receptors.

Agonism is not simply the undifferentiated celebration of antagonism:

Orexin agonism may explain the anti-narcoleptic action of the drug modafinil which was already being used only a year prior.

Management of overdose should be focused on treating symptoms of mu-opioid agonism.

The mechanism of action is thought to be serotonin receptor agonism, much like other classic psychedelics.

If the protein is a receptor, ligand binding may result in agonism or antagonism.

An advocate of the political theory of agonism (or 'agonistic pluralism').

It may result from serotonin receptor agonism.

Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism.

Its mechanism of action involves agonism of the P2Y2 purinogenic receptor.

Agonism is a political theory that emphasises the potentially positive aspects of certain (but not all) forms of political conflict.

Because of its somewhat selective CB agonism, it is used experimentally as an immunosuppressant.

Although complete selectivity between receptor agonism is rarely achieved, some agents have partial selectivity.

Metabotropic glutamate receptor 2 agonism has been seen as a promising strategy in the development of novel antipsychotics.

Terms that describe this phenomenon are "functional selectivity", "protean agonism", or selective receptor modulators.